DISCOVERY LABORATRS (DSCO) 0.50 red arrow -$0.01 (-1.96%) 08:22PM (15 mins delay)


DSCO
$0.50    -$0.01  (-1.96%)

You need to upgrade your Flash Player
Today 5d 1m 3m 1y 5y 10y
Last: $0.50 High: $0.52
Prev Close: $0.51 Low: $0.50
Open: $0.51 Mkt Cap: $78M
Change: -$0.01 ( -1.96% ) 52Wk High: $2.40
Vol: 1,539,021 52Wk Low: $0.33
Avg Volume: 2,193,764 Shares: 153.89B
EPS: -0.26 PE Ratio: -

Start trading DSCO with real money!

Company Description

A biotechnology company, which develops Surfactant Replacement Therapies for respiratory disorders and diseases.

What do you think about DSCO?

140 characters max. Total left: 140
Also post on Twitter. (What is Twitter?)

Comments on DSCO

. .
Sep 17 3:15 PM
Please be Bearish! i'm losing money! - DSCO
Comment
Shahid Nisar
Jul 31 3:40 PM
started an entry limit for its support at .40, for 20k shares, need to load up on this one, tech looks great, 4q of positive earnings pt 2 - Comment
Paul & Shark
Jul 04 9:33 AM
This is a warning and example which shows how in a bear market losing money companies get punished instantly. Check your other stocks too. - Comment
Paul & Shark
Jul 04 9:31 AM
Dear investors, this is what happens when you buy stocks without looking into balance sheet first, DSCO really has nothing to show there. - Comment
Sanny Djoeva
May 29 10:45 AM
Synthetic surfactant could b huge.only thing that prevented approval last round was stability/shelf-life, not the actual drug itself - Comment
Kim Odonnell
May 18 1:42 PM
surfaxin should finally get approval - DSCO
Comment

DISCOVERY LABORATRS (DSCO) Stock News & Analysis

stock news Report of unscheduled material events or corporate changes - Form 8-K 03/15/2010 SEC Filings
stock news Discovery Labs Reports Fourth Quarter 2009 Financial Results and Provides Business Update 03/10/2010 GlobeNewswire
stock news Annual report which provides a comprehensive overview of the company for the past year - Form 10-K 03/10/2010 SEC Filings
stock news Discovery Labs Announces Completion of $16.5 Million Public Offering 02/23/2010 GlobeNewswire
stock news Liberty Analytics Co. Initiates Independent Research Coverage on Discovery Laboratories, Inc. 02/19/2010 GlobeNewswire
stock news Prospectus filed pursuant to Rule 424(b)(5) - Form 424B5 02/19/2010 SEC Filings
stock news Discovery Labs Prices $16.5 Million Public Offering of Common Stock and Warrants 02/18/2010 GlobeNewswire
stock news Report of unscheduled material events or corporate changes - Form 8-K 02/18/2010 SEC Filings
stock news Discovery Labs Announces Proposed Public Offering of Common Stock and Warrants 02/17/2010 GlobeNewswire
stock news Biotech Stock Alert for Discovery Laboratories Issued by StockPreacher 02/17/2010 GlobeNewswire
stock news Prospectus filed pursuant to Rule 424(b)(5) - Form 424B5 02/17/2010 SEC Filings
stock news Discovery Labs Receives FDA Guidance Regarding Pathway to Potential SURFAXIN(R) Approval 02/16/2010 GlobeNewswire
stock news Report of unscheduled material events or corporate changes - Form 8-K 02/16/2010 SEC Filings
stock news An amendment to the SC 13G filing - Form SC 13G/A 02/12/2010 SEC Filings
stock news Annual statement of changes in beneficial ownership of securities - Form 5 02/09/2010 SEC Filings

Write Your Own Stock Analysis

Do you have a hot tip on a stock? Share it with our community. Get started by entering the company name or symbol below.

New DSCO Stock Picks

stock pick type FDA announcement on 4/17 will make or break DSCO
Posted 337 days ago on 4/16/09 by Rainy Day
stock pick type Eyeing Micro-Cap Bio-Pharma Opportunities
Posted 473 days ago on 12/01/08 by Mike Havrilla
stock pick type Buy before big news released
Posted 567 days ago on 8/29/08 by J E
stock pick type Surfaxin almost guaranteed approval
Posted 682 days ago on 5/06/08 by Jan Ocken
stock pick type Grab Your nuts and Cross your fingers.
Posted 687 days ago on 4/30/08 by Jeff Nix


Make a suggestion for this page

Investing Channel Logo

Data powered by QuoteMedia (Terms of Use). Data delayed 15 minutes unless otherwise indicated.